Cochlear-backed Epiminder hits the ASX – and plunges
As omens go, epilepsy medtech Epiminder’s ASX debut on Monday, perhaps the stock exchange’s outage to start December wasn’t the best of signs. A technical glitch meant price-sensitive announcements couldn’t be published for several hours and 50 ASX-listed companies were forced into trading halts. Epiminder’s (ASX: EPI) initial public offering (IPO) at $1.50 per share… Read more »














